92 related articles for article (PubMed ID: 10436961)
1. [The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
Xu Y; Wang H; Chen M
Zhonghua Nei Ke Za Zhi; 1997 Aug; 36(8):540-2. PubMed ID: 10436961
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Esposito S; Galante D; Barba D
Chemioterapia; 1986 Apr; 5(2):101-4. PubMed ID: 3518963
[TBL] [Abstract][Full Text] [Related]
3. [Antibacterial activity of cefmenoxime against clinical isolates. Comparative study].
Takahashi C; Miyazawa K
Jpn J Antibiot; 1985 Jan; 38(1):27-30. PubMed ID: 3886949
[TBL] [Abstract][Full Text] [Related]
4. [In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Le Noc P; Bryskier A; Le Noc D
Pathol Biol (Paris); 1986 Jun; 34(5 Pt 2):567-71. PubMed ID: 3534744
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal activity of cefazolin, cefoxitin, and cefmetazole against Escherichia coli and Klebsiella pneumoniae.
Goto S; Sakamoto H; Ogawa M; Tsuji A; Kuwahara S
Chemotherapy; 1982; 28(1):18-25. PubMed ID: 7035088
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activity of ceftizoxime against gram-negative strains.
Debbia E; Soro O
Chemioterapia; 1985 Apr; 4(2):166-9. PubMed ID: 3891115
[TBL] [Abstract][Full Text] [Related]
7. Infections of cefotaxime-resistant and cefmetazole-susceptible Escherichia coli and Klebsiella pneumoniae in children.
Wu TZ; Hsueh PR; Chang LY; Lu CY; Wang CY; Yang CY; Shao PL; Lee PI; Lee CY; Huang LM
J Microbiol Immunol Infect; 2005 Apr; 38(2):112-6. PubMed ID: 15843855
[TBL] [Abstract][Full Text] [Related]
8. Cefmetazole: a broad spectrum cephem antibiotic effective on methicillin- and cephem-resistant Staphylococcus aureus.
Yokota T; Yoshida R; Utsui Y; Tajima M
Drugs Exp Clin Res; 1985; 11(1):29-38. PubMed ID: 3915273
[TBL] [Abstract][Full Text] [Related]
9. [In vitro susceptibility of Escherichia coli and Klebsiella sp. to antibiotics].
Igari J; Shitara M; Shitara M; Yoshimoto K; Hayashi Y
Jpn J Antibiot; 1990 Apr; 43(4):659-69. PubMed ID: 2199690
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of extended-spectrum beta-lactamases in nosocomial Escherichia coli and Klebsiella spp. strains isolated from blood cultures].
Zarakolu P; Metan G; Hasçelik G; Akova M
Mikrobiyol Bul; 2007 Oct; 41(4):579-84. PubMed ID: 18173077
[TBL] [Abstract][Full Text] [Related]
11. [Susceptibility of bacteria to selected cephalosporins of the II and III generation].
Nowakowska K; Szozda G; Pawluch D; Drejewicz H; Siwińska-Gołebiowska H
Med Dosw Mikrobiol; 1993; 45(2):177-82. PubMed ID: 8309293
[TBL] [Abstract][Full Text] [Related]
12. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
Shah PM; Stille W
Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
[TBL] [Abstract][Full Text] [Related]
13. Extended spectrum b lactamases (ESBL) in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
Duttaroy B; Mehta S
Indian J Pathol Microbiol; 2005 Jan; 48(1):45-8. PubMed ID: 16758790
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Masuyoshi S; Hiraoka M; Inoue M; Tomatsu K; Hirano M; Mitsuhashi S
Drugs Exp Clin Res; 1989; 15(1):1-10. PubMed ID: 2663406
[TBL] [Abstract][Full Text] [Related]
15. [Activity of 9 beta-lactam antibiotics combined with clavulanic acid or sulbactam against the strains of broad-spectrum beta-lactamase (CTX-1) producing Enterobacteriaceae isolated at the Henri Mondor Hospital].
Legrand P; Soussy CJ; Orsoni A; Brickley X; Duval J
Pathol Biol (Paris); 1988 May; 36(5):425-9. PubMed ID: 3043338
[TBL] [Abstract][Full Text] [Related]
16. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
17. [In vitro activity of cefoxitin, a new cephalosporin (author's transl)].
Shah PM; Zwischenbrugger H; Stille W
MMW Munch Med Wochenschr; 1976 Nov; 118(45):1469-72. PubMed ID: 825763
[TBL] [Abstract][Full Text] [Related]
18. Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Verbist L
Arzneimittelforschung; 1981; 31(6):982-6. PubMed ID: 6266430
[TBL] [Abstract][Full Text] [Related]
19. [Comparative in vitro activity of 2 monobactams (RO 172301 (AMA 1080)and aztreonam), ceftazidime and cefotaxime on Gram-negative bacilli].
Thabaut A; Meyran M; Huerre M
Pathol Biol (Paris); 1985 May; 33(5):404-7. PubMed ID: 3929217
[TBL] [Abstract][Full Text] [Related]
20. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
